Enlightify (ENFY) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
20 Apr, 2026Executive summary
Fiscal 2024 net sales declined 22.8% year-over-year to $95.8M, driven by lower fertilizer sales, especially at Gufeng.
Net loss widened to $28.4M from $13.3M in 2023, mainly due to higher general and administrative expenses and increased bad debt expense.
Gross profit margin improved to 20.6% from 17.7% despite lower sales, reflecting cost controls.
The company operates four segments: Jinong (fertilizer), Gufeng (fertilizer), Yuxing (agricultural products), and Antaeus (Bitcoin mining).
Financial highlights
Jinong sales fell 18.1% to $33.0M; Gufeng sales dropped 29.5% to $52.2M; Yuxing sales decreased 2.5% to $9.4M; Antaeus (Bitcoin) sales rose 511% to $1.3M.
Total fertilizer volume sold declined 20.8% to 139,070 metric tons.
Gross profit was $19.7M, down 10% year-over-year.
General and administrative expenses increased 49.9% to $40.8M, mainly due to higher bad debt expense.
Cash and cash equivalents at year-end were $58.8M, down 17.4% from prior year.
Accounts receivable stood at $16.5M, with a 58% allowance for doubtful accounts.
Outlook and guidance
Management intends to retain most available funds for business operations and expansion.
Plans include expanding fertilizer production lines, developing new products, and further integrating U.S. digital asset mining operations.
The company may seek additional financing for expansion but cannot guarantee availability or terms.
Latest events from Enlightify
- FY2025 net sales fell 21.5% to $75.3M; NYSE delisting and net loss of $15.6M raise going concern doubts.ENFY
Q4 202520 Apr 2026 - Net sales dropped 16.7% to $14.5M, with net income rebounding to $1.1M amid NYSE delisting.ENFY
Q3 202512 Dec 2025 - Annual Meeting to elect seven directors and ratify auditor, with focus on governance and oversight.ENFY
Proxy Filing2 Dec 2025 - Annual meeting to elect directors, ratify auditors, and expand the equity incentive plan.ENFY
Proxy Filing2 Dec 2025 - Annual meeting to vote on director elections, equity plan amendment, stock issuance, and reverse split.ENFY
Proxy Filing2 Dec 2025 - Shareholders to vote on director elections, equity plan, stock issuance, and reverse split.ENFY
Proxy Filing21 Nov 2025 - Net sales and profits fell year-over-year; NYSE delisting heightens going concern risks.ENFY
Q2 202517 Nov 2025 - Net loss narrowed 56.5% year-over-year to $7.85M on a 22.7% sales decline, with improved margins.ENFY
Q1 202510 Jul 2025